House of Commons
As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.
EDM #849
Tabled 06 March 2015
2014-15 Session
That this House notes the ten-fold increase over 10 years of labelling children with diagnoses of attention deficit hyperactivity disorder (ADHD); further notes the guidance by NICE on the serious potential side effects of pharmaceutical drugs prescribed for this condition; affirms that there are serious concerns about the overuse of drug treatment and notes that the UN Committee on the Rights of the Child has expressed deep concern about children being misdiagnosed with ADHD; and calls for a significant review of existing treatments and for existing studies and non-drug methods for treating children with symptoms diagnosed as ADHD to be looked into in greater depth including potential causes such as toxins in the environment, poor nutrition and other biophysical reasons.

Signatures (30)

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
In addition to the sponsors, the following Members have signed to support the motion.
There are no withdrawn signatures for this Motion